Position in HIMS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$1,089,296
+$478,849 QoQ
Shares Held
31,419
+6.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#209
of 503 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $26,283,345 across 23 Drug Manufacturers - Specialty & Generic names. HIMS ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
109,299 | $7,854,226 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
27,419 | $4,621,198 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
7,508 | $4,068,059 | |
| 4 | VTRS |
Viatris Inc
|
128,327 | $2,037,832 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
59,638 | $1,467,691 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
This page
|
31,419 | $1,089,296 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
9,599 | $1,064,913 | |
| 8 | ALKS |
Alkermes plc.
|
16,250 | $851,500 |
All Filings in HIMS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,089,296 | 31,419 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $610,447 | 29,405 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $816,523 | 25,147 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,599,220 | 28,195 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,384,633 | 27,776 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $826,218 | 27,960 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $341,010 | 14,103 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $231,410 | 12,563 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $241,835 | 11,978 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||